Jim Cramer says stocks are caught between the forces of inflation and deflation, and investors need to find companies that can adapt.

Cathie Wood's Ark Investment bought shares of Germany’s Crispr Tuesday, a media report says. The stock slid on Wednesday.

'These data open a new era of medicine – one that holds the potential of curing genetic disease,' Intellia said. Its shares are higher.

Intellia Therapeutics rises and other gene-editing stocks follow suit.

Jim Cramer says on days like this, investors are going after what's new or exciting, searching for what he calls 'coolness-per-share.'

Intellia Therapeutics, QAD, Etsy, NRG Energy and Nvidia are five top stock gainers for Monday.

The genetics space has everyone's attention on Monday as traders look to capitalize on the potential of these stocks. Let's look at a few charts.

Stocks moving in premarket trading Monday include Intellia Therapeutics, Boeing, Nvidia, Arbutus Biopharma and NRG Energy.

Intellia Therapeutics shares surge after it and Regeneron report positive results from a clinical trial to treat a genetic disorder called Transthyretin Amyloidosis.

Universal Studios has begun construction on Epic Universe, its third theme park planned for Florida.

The e-commerce giant has just made a decision that suggests the health of the economy is not improving.

The Tesla CEO has put his offer for Twitter back on the table. And as rich as he is, investors are worried.